Evome Medical Technologies Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was CAD 15.6 million. Basic loss per share from continuing operations was CAD 0.21.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.12 CAD | 0.00% |
|
+50.00% | -42.86% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-42.86% | 7.09M | |
+3.26% | 209B | |
+6.55% | 183B | |
+31.66% | 158B | |
+34.32% | 114B | |
+5.13% | 67.29B | |
+19.33% | 54.83B | |
-3.30% | 46.88B | |
-4.84% | 38.58B | |
+3.83% | 36.65B |
- Stock Market
- Equities
- BRTL Stock
- News Evome Medical Technologies Inc.
- Evome Medical Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023